Cost-Utility of Acromegaly Pharmacological Treatments in a French Context

Cost-Utility of Acromegaly Pharmacological Treatments in a French Context

ObjectiveEfficacy of pharmacological treatments for acromegaly has been assessed in many clinical or real-world studies but no study was interested in economics evaluation of these treatments in France. Therefore, the objective of this study was to estimate the cost-utility of second-line pharmacolo...

Full description

Bibliographic Details
Main Authors: Thierry Brue, Philippe Chanson, Patrice Rodien, Brigitte Delemer, Delphine Drui, Lucile Marié, Laurène Juban, Lara Salvi, Robin Henocque, Gérald Raverot
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Endocrinology
Subjects:
acromegaly
cost-utility
growth hormone
insulin-like growth factor-1
QALY
pasireotide
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.745843/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.745843/full

Similar Items